RCT Favors High-dose Corticosteroids for Trigger Finger — We’re Leery

Something bothered us about this one, so we dug up all the case reports we could find about tendon ruptures after these shots, and...

RCT Favors High-dose Corticosteroids for Trigger Finger — We’re Leery
💡
Editor’s Note: Sometimes at CORRelations, we’ll cover an article we think is likely to cross your desk, but is one whose message we have reservations about. Here’s one. — SSL

What’s the Claim?

A randomized trial compared doses of corticosteroid (triamcinolone [Kenalog]) when used for injections to treat trigger finger and found that the highest Kenalog dose explored — 20 mg — resulted in the highest percentage of patients still enjoying relief of symptoms at 6 months: 79%, compared to 62% and 52% in the 10 mg and 5 mg groups, respectively. QuickDASH scores also were highest in the highest-dose group, as well.

We’re covering this one because it was the first study mentioned in the recent “What's New in Hand Surgery” review in JBJS, so the finding is likely to tempt you.

  • We suggest steering clear. Read on for why.

How’s It Stack Up?